Escalon Medical Corp.
ESMC · Healthcare · $1.5M mkt cap · FY2025 filings · Shallow moat ·
Doesn't clear the bar
The four filters
Median gross margin 44.9% over 10y, very stable.
Median ROIC -26.8%, above the 9% hurdle in 30% of years.
Net debt/EBITDA n/ax, interest coverage 6x.
Owner earnings trend unclear, share count shrinking (buybacks).
Margin of safety
- Owner earnings (normalized)
- $66513
- Est. intrinsic value / share
- $0.10
- Recent price
- $0.20
- Discount to value
- 101% above value
Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).
Fundamentals
There's no normalized fundamentals series for ESMC yet — it appears once ingest has processed its filings.
Moat Score history
Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.
Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars
None yet — ESMC has read Shallow moat for every logged capture since Jul 17, 2026.
Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.
Healthcare context
#208 of 440 scored Healthcare companies, ranked by Moat Score.
Nearest peers by Moat Score
- #206AVTX Avalo Therapeutics, Inc.42.9 out of 100, Shallow moatShallow moat
- #207KEQU Kewaunee Scientific Corporation42.7 out of 100, Shallow moatShallow moat
- #209VERU VERU INC.42.6 out of 100, Shallow moatShallow moat
- #210IONS IONIS PHARMACEUTICALS, INC.42.6 out of 100, Shallow moatShallow moat
Compare ESMC with its nearest peers →All Healthcare companies on the Index →
Common questions about ESMC
- Does Escalon Medical Corp. have an economic moat?
- Based on its FY2025 SEC filings, the Moat Index scores Escalon Medical Corp. (ESMC) 42.6 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 75, returns on capital 11, balance-sheet safety 37, capital discipline 47.
- Is ESMC stock trading below its intrinsic value?
- Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $0.10 per share versus a recent price of $0.20 — 101% above value. This is an educational estimate computed from primary SEC filings, not investment advice.
- How has ESMC's Moat Score changed over time?
- The record logs 2 readings since Jul 17, 2026; the latest reads 42.6 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.